Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study

Transplantation

Volumn 82, Issue 1, 2006, Pages 136-139

  Englesbe, Michael J ^a   Moyer, Alice ^a   Kim, Dean Y ^b   Granger, Darla K ^c   Pietroski, Richard ^d   Yoshida, Atsushi ^b   Arenas, Juan D ^b   Oh, Henry ^c   Pelletier, Shawn J ^a   Campbell Jr , Darrell A ^a   Punch, Jeffrey D ^a   Magee, John C ^a   Gruber, Scott A ^e   Sung, Randall S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^d Gift of Life Michigan   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical transplantation; Complications of clinical transplantation; Histidine tryptophan ketoglutarate (HTK); Organ preservation; Pancreas; Surgical

Indexed keywords

AMYLASE; HISTIDINE TRYPTOPHAN KETOGLUTARATE PRESERVATION SOLUTION; PRESERVATION SOLUTION; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION; BRETSCHNEIDER CARDIOPLEGIC SOLUTION; GLUCOSE; MANNITOL; POTASSIUM CHLORIDE; PROCAINE;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT PRESERVATION; GRAFT SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGAN PRESERVATION; OUTCOME ASSESSMENT; PANCREAS ABSCESS; PANCREAS PRESERVATION; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; DRUG EFFECT; GRAFT REJECTION; PANCREAS; PANCREAS TRANSPLANTATION;

ADULT; FEMALE; GLUCOSE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MALE; MANNITOL; ORGAN PRESERVATION SOLUTIONS; PANCREAS; PANCREAS TRANSPLANTATION; POTASSIUM CHLORIDE; PROCAINE;

EID: 33747465871     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000225764.21343.e3     Document Type: Article

References (17)

1. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28(5): 295.
2. Brandhorst H, Hering BJ, Brandhorst D, et al. Comparison of histidine-tryptophane-ketoglutarate (HTK) and University of Wisconsin (UW) solution for pancreas perfusion prior to islet isolation, culture and transplantation. Transplant Proc 1995; 27(6): 3175.
3. Agarwal A, Goggins WC, Pescovitz MD, et al. Comparison of histidine-tryptophan ketoglutarate and university of wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005; 37(5): 2016.
4. Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003; 88(3): 145.
5. Gubernatis G, Pichlmayr R, Lamesch P, et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 1990; 375(2): 66.
6. Potdar S, Malek S, Eghtesad B, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18(6): 661.
7. Pokorny H, Rasoul-Rockenschaub S, Langer F, et al. Histidine-tryptophan- ketoglutarate solution for organ preservation in human liver transplantation-a prospective multi-centre observation study. Transpl Int 2004; 17(5): 256.
8. Kaplan EL. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
9. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003. Clin Transpl 2003; 21.
10. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002. Clin Transpl 2002; 41.
11. Gruessner AC, Sutherland DE. Analysis of United States (US) and non-US pancreas transplants reported to the United network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR) as of October 2001. Clin Transpl 2001; 41.
12. Fridell JA, Agarwal A, Milgrom ML, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77(8): 1304.
13. Gruber SA, Katz S, Kaplan B, et al. Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. Transplantation 2000; 70(2): 388.
14. Stratta RJ, Alloway RR, Lo A, Hodge EE. Does surgical technique influence outcomes after simultaneous kidney-pancreas transplantation? Transplant Proc 2004; 36(4): 1076.
15. Stratta RJ. Surgical nuances in pancreas transplantation. Transplant Proc 2005; 37(2): 1291.
16. Hesse UJ, Troisi R, Jacobs B, et al. Cold preservation of the porcine pancreas with histidine-tryptophan-ketoglutarate solution. Transplantation 1998; 66(9): 1137.
17. Hesse UJ, Troisi R, Jacobs B, et al. Pancreas preservation with HTK solution in the pig. Transplant Proc 1997; 29(8): 3522.